Fast-Food Chains Adapt Menus for GLP-1 Drug Users

Fast-food chains are updating menus with high-protein and low-calorie options to cater to GLP-1 users. McDonald's, Shake Shack, and Chipotle lead the trend.

Editorial Desk

September 26, 2026 One Min Read

POLICY WIRE — New York, United States — Major fast-food chains are overhauling their menus to appeal to consumers using GLP-1 weight-loss drugs, introducing more protein-rich and lower-calorie options to meet evolving dietary preferences.

McDonald’s recently unveiled a range of healthier choices, including grilled chicken sandwiches, wraps, and egg bites, as part of an $8.5 billion global restaurant renovation. The move comes as the company seeks to align its offerings with the changing needs of customers who are on GLP-1 medications.

📄 POLICY WIRE WHITEPAPER PUBLISHED: PAKISTAN’S NATIONAL SECURITY POLICY PRIORITIES

👉 READ BY CLICKING HERE

McDonald’s CEO Chris Kempczinski noted that even as people begin using these drugs, they still desire familiar food. Meanwhile, Skye Anderson, president of McDonald’s USA, emphasized that the company is adjusting its menu to better serve those seeking higher protein intake and greater flexibility in meal portions. Other chains, such as Shake Shack and Chipotle, have also introduced specialized options, including gluten-free, vegetarian, and GLP-1-friendly dishes, to support customers on weight-loss journeys.

Reporting by Policy-Wire (PW)

Author

Editorial Desk

Policy Wire is your go-to editorial hub for insightful perspectives and informed analysis on pressing policy issues, both regionally and globally. Over the years, Policy Wire has collaborated with leading international news agencies—including AFP, AP, Reuters, and others—to provide fact-based reporting and nuanced commentary. With a commitment to clarity and credibility, we aim to bridge the gap between complex policy debates and public understanding, ensuring that our readers stay informed on the issues shaping the world today.